The latest report by IMARC Group, titled “Needle-free Drug Delivery Technology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. The global needle-free drug delivery technology market size reached US$ 4.18 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.72 Billion by 2028, exhibiting a growth rate (CAGR) of 5.22% during 2023-2028.
Needle-free drug delivery technology encompasses various methods of administering medications to patients without the need for conventional needles. These innovative approaches include micronozzle jet injectors, transdermal patches, inhalers, disposable cartridge injectors, nasal sprays, and ultrasound waves. One of its main advantages is the elimination of syringes or needles, which can carry the risk of being used or contaminated. Compared to traditional needle-based delivery systems, needle-free drug delivery technology offers several advantages, such as reduced pain, minimal discomfort and anxiety, improved patient compliance, dosage customization, enhanced convenience for healthcare professionals, and lower risk of injuries and infections. It also provides the added benefits of faster medication delivery and improved drug absorption, minimizing complications and increasing the overall effectiveness of treatments. In addition, it is an eco-friendly technology as it reduces hazardous waste, lowers manufacturing emissions, and eliminates the need for product disposal. As a result, needle-free drug delivery technology finds extensive applications in vaccinations, insulin delivery, pain management, hormone therapy, and the treatment of allergies, cancer, respiratory conditions, and other chronic diseases across the globe.
Request Your Sample Report Now: https://www.imarcgroup.com/needle-free-drug-delivery-technology-market/requestsample
Needle-free Drug Delivery Technology Market Trends and Drivers:
The global needle-free drug delivery technology market is primarily driven by the rising prevalence of chronic diseases, such as diabetes, cancer, Crohn’s disease, multiple sclerosis, arthritis, osteoporosis, and cardiovascular diseases (CVDs). Moreover, the increasing use of needle-free drug delivery in administering insulin and medications to patients with chronic illnesses, as it offers a pain-free and comfortable alternative that improves treatment outcomes, reduces the risk of infections, and enhances patients’ overall quality of life, is positively influencing the market growth. Apart from this, the surging adoption of needle-free drug delivery technology to enhance medication adherence, optimize drug absorption, boost treatment effectiveness, and minimize complications associated with traditional needle-based methods is another major growth-inducing factor. Additionally, the introduction of laser-powered needle-free injection technology (NFIT) that uses laser-based systems to precisely deliver microscopic drug jets into the skin is propelling the market growth. Besides this, the rising product utilization in veterinary care to facilitate humane and stress-free administration of vaccines, medications, and anesthesia to animals has catalyzed market growth. Furthermore, several favorable initiatives undertaken by governments of numerous countries for promoting the adoption of needle-free drug delivery systems and supporting the development of advanced technologies are contributing to the market growth. Other factors, including the rising prevalence of infectious diseases, a growing geriatric population, significant advancements in the healthcare industry, extensive research and development (R&D) activities, and increasing consumer awareness about the benefits of needle-free drug delivery technology, are also anticipated to drive the market further.
Report Segmentation:
The report has segmented the market into the following categories:
Product Insights:
- Inhaler
- Jet Injector
- Novel Needles
- Transdermal Patch
- Others
Application Insights:
- Vaccine Delivery
- Pain Management
- Insulin Delivery
- Others
End User Insights:
- Hospitals and Clinics
- Homecare Settings
- Research Laboratories
- Academics
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Akra Dermojet
- Antares Pharma Inc. (Halozyme Therapeutics Inc.)
- Crossject, Mika Medical Co.
- PharmaJet
- Portal Instruments Inc.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
